source
- Stage IV Breast Cancer Cases Rise Over Past Decade, Dana-Farber Study ShowsA recent analysis by Dana-Farber Cancer Institute examined breast cancer diagnoses over the past ten years. The researchers found that the number of patients diagnosed with stage IV disease has ri…
- Degron Therapeutics raises $40M in Series A extension, total $95M, as Cabaletta releases early CAR‑T dataDegron Therapeutics, a US‑China biotech focused on molecular‑glue degrader technology, announced an additional $40 million in Series A extension funding, bringing its total capital raised to $95 mi…